Literature DB >> 33441902

Effect of lipopolysaccharide and polyinosinic:polycytidylic acid in a murine model of nasal polyp.

Jee Hye Wee1, Young-Kyung Ko2, Roza Khalmuratova3, Hyun-Woo Shin3,4, Dae Woo Kim5, Chae-Seo Rhee6.   

Abstract

Several factors, including bacterial and viral infections, have been associated with rhinosinusitis and nasal tissue remodelling that may result in nasal polyp formation. However, the potential role of bacterial or viral stimuli triggering polyp development is unclear. Here, we used lipopolysaccharide (LPS) and polyinosinic:polycytidylic acid [poly(I:C)] in a murine model of allergic rhinosinusitis to compare different effects of bacterial- and virus-derived stimuli in the pathogenesis of nasal polyp formation. Briefly, BALB/c mice were sensitised and challenged with ovalbumin and staphylococcal enterotoxin, with or without LPS or poly(I:C), and the consequent histopathological profiles, cytokines, and systemic humoral responses were studied. While no significant differences in polyp formations and epithelial disruptions were observed among the experimental groups, the local cell recruitment patterns slightly differed in animals that received either LPS or poly(I:C). Additionally, the local immune environments generated by LPS or poly(I:C) stimulation varied. LPS stimulation induced a marked Th1/Th17 response and predominantly neutrophilic nasal polyp formations, whereas poly(I:C) induced a Th2-skewed environment in neutrophilic nasal polyp development. Overall, our findings show that both cell recruitment patterns and local immune environments induced by these two stimuli differ, which may have implications in the physiopathology of rhinosinusitis with nasal polyp.

Entities:  

Year:  2021        PMID: 33441902      PMCID: PMC7806732          DOI: 10.1038/s41598-020-80483-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

1.  IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.

Authors:  Hyun-Woo Shin; Dong-Kyu Kim; Min-Hyun Park; Kyoung Mi Eun; Mingyu Lee; Daeho So; Il Gyu Kong; Ji-Hun Mo; Min-Suk Yang; Hong Ryul Jin; Jong-Wan Park; Dae Woo Kim
Journal:  J Allergy Clin Immunol       Date:  2015-02-25       Impact factor: 10.793

2.  A Recently Established Murine Model of Nasal Polyps Demonstrates Activation of B Cells, as Occurs in Human Nasal Polyps.

Authors:  Dong-Young Kim; Sun Hye Lee; Roderick G Carter; Atsushi Kato; Robert P Schleimer; Seong H Cho
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

3.  IL-33 induces skin inflammation with mast cell and neutrophil activation.

Authors:  Axel J Hueber; Jose C Alves-Filho; Darren L Asquith; Chesney Michels; Neal L Millar; James H Reilly; Gerry J Graham; Foo Y Liew; Ashley M Miller; Iain B McInnes
Journal:  Eur J Immunol       Date:  2011-06-24       Impact factor: 5.532

4.  The role of interleukin-33 in chronic rhinosinusitis.

Authors:  Dong-Kyu Kim; Hong Ryul Jin; Kyoung Mi Eun; Ji-Hun Mo; Seong H Cho; Sohee Oh; David Cho; Dae Woo Kim
Journal:  Thorax       Date:  2016-11-24       Impact factor: 9.139

Review 5.  Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.

Authors:  Jennifer Vandooren; Philippe E Van den Steen; Ghislain Opdenakker
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-04-02       Impact factor: 8.250

6.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Authors:  Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald
Journal:  Rhinology       Date:  2012-03       Impact factor: 3.681

7.  Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania.

Authors:  Xiangdong Wang; Nan Zhang; Mingyu Bo; Gabriele Holtappels; Ming Zheng; Hongfei Lou; Hong Wang; Luo Zhang; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2016-07-15       Impact factor: 10.793

8.  Three-dimensional analysis of rodent paranasal sinus cavities from X-ray computed tomography (CT) scans.

Authors:  Jonathan E Phillips; Lunan Ji; Maria A Rivelli; Richard W Chapman; Michel R Corboz
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

9.  The Role of IL-17 in a Lipopolysaccharide-Induced Rhinitis Model.

Authors:  Jun Sang Bae; Ji Hye Kim; Eun Hee Kim; Ji Hun Mo
Journal:  Allergy Asthma Immunol Res       Date:  2017-03       Impact factor: 5.764

10.  Sinonasal Delivery of Resveratrol via Mucoadhesive Nanostructured Microparticles in a Nasal Polyp Mouse Model.

Authors:  Mingyu Lee; Chun Gwon Park; Beom Kang Huh; Se-Na Kim; Seung Ho Lee; Roza Khalmuratova; Jong-Wan Park; Hyun-Woo Shin; Young Bin Choy
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

View more
  1 in total

1.  Elovanoids Counteract Inflammatory Signaling, Autophagy, Endoplasmic Reticulum Stress, and Senescence Gene Programming in Human Nasal Epithelial Cells Exposed to Allergens.

Authors:  Alfredo Resano; Surjyadipta Bhattacharjee; Miguel Barajas; Khanh V Do; Roberto Aguado-Jiménez; David Rodríguez; Ricardo Palacios; Nicolás G Bazán
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.